Guía de tratamiento antimicrobiano de la infección por Staphylococcus aureus

No abstract is available for this paper.

• Publication year

  2013

• Venue

  Revista Espanola De Quimioterapia

• Publication date

  Unknown publication date

• Fields of study

  Not labeled

• Identifiers

  No identifiers available.

• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar

• No claims are published for this paper.

• No concepts are published for this paper.

• Efficacy of linezolid versus a pharmacodynamically optimized vancomycin therapy in an experimental pneumonia model caused by methicillin-resistant Staphylococcus aureus.

  2012cited by this paper
• Linezolid as rescue treatment for left-sided infective endocarditis: an observational, retrospective, multicenter study

  2012cited by this paper
• Evaluation of vancomycin serum trough concentrations and outcomes in meticillin-resistant Staphylococcus aureus bacteraemia.

  2012cited by this paper
• Performance of a vancomycin dosage regimen developed for obese patients.

  2012cited by this paper
• Vancomycin MICs do not predict the outcome of methicillin-resistant Staphylococcus aureus bloodstream infections in correctly treated patients.

  2012cited by this paper
• Determinants of early inadequate vancomycin concentrations during continuous infusion in septic patients.

  2012cited by this paper
• Efficacy of linezolid compared to vancomycin in an experimental model of pneumonia induced by methicillin-resistant Staphylococcus aureus in ventilated pigs*

  2012cited by this paper
• Influence of teicoplanin MICs on treatment outcomes among patients with teicoplanin-treated methicillin-resistant Staphylococcus aureus bacteraemia: a hospital-based retrospective study.

  2012cited by this paper
• Guidelines for the diagnosis and antibiotic treatment of endocarditis in adults: a report of the Working Party of the British Society for Antimicrobial Chemotherapy.

  2012cited by this paper
• Glycopeptide Antibiotics

  2012cited by this paper
• Augmented renal clearance in septic patients and implications for vancomycin optimisation.

  2012cited by this paper
• Continuous versus intermittent infusion of vancomycin for the treatment of Gram-positive infections: systematic review and meta-analysis.

  2012cited by this paper
• Characteristics and outcomes of methicillin-resistant staphylococcus aureus bloodstream infections in patients with cancer treated with vancomycin: 9-year experience at a comprehensive cancer center.

  2012cited by this paper
• Altered vancomycin pharmacokinetics in obese and morbidly obese patients: what we have learned over the past 30 years.

  2012cited by this paper
• Methicillin Resistance Reduces the Virulence of Healthcare-Associated Methicillin-Resistant Staphylococcus aureus by Interfering With the agr Quorum Sensing System

  2012cited by this paper
• Methicillin-Resistant Staphylococcus aureus Meningitis in Adults: A Multicenter Study of 86 Cases

  2012cited by this paper
• A Novel δ-Hemolysis Screening Method for Detecting Heteroresistant Vancomycin-Intermediate Staphylococcus aureus and Vancomycin-Intermediate S. aureus

  2012cited by this paper
• Relationship between Vancomycin-Resistant Staphylococcus aureus, Vancomycin-Intermediate S. aureus, High Vancomycin MIC, and Outcome in Serious S. aureus Infections

  2012cited by this paper
• Vancomycin-intermediate Staphylococcus aureus selected during vancomycin therapy of experimental endocarditis are not detected by culture-based diagnostic procedures and persist after treatment arrest.

  2012cited by this paper
• Testing the mutant selection window in rabbits infected with methicillin-resistant Staphylococcus aureus exposed to vancomycin.

  2012cited by this paper
• The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.

  2012cited by this paper
• Serine/threonine phosphatase Stp1 contributes to reduced susceptibility to vancomycin and virulence in Staphylococcus aureus.

  2012cited by this paper
• Prediction of Failure in Vancomycin-Treated Methicillin-Resistant Staphylococcus aureus Bloodstream Infection: a Clinically Useful Risk Stratification Tool

  2011cited by this paper
• Vancomycin: we can't get there from here.

  2011cited by this paper
• Comparison of ceftaroline fosamil, daptomycin and tigecycline in an experimental rabbit endocarditis model caused by methicillin-susceptible, methicillin-resistant and glycopeptide-intermediate Staphylococcus aureus.

  2011cited by this paper
• Initial dosing of vancomycin in critically ill patients.

  2011cited by this paper
• Clinical effectiveness and risk of emerging resistance associated with prolonged use of antibiotic-impregnated catheters: More than 0.5 million catheter days and 7 years of clinical experience*

  2011cited by this paper
• Vancomycin Bactericidal Activity as a Predictor of 30-Day Mortality in Patients with Methicillin-Resistant Staphylococcus aureus Bacteremia

  2011cited by this paper
• Optimal Dose of Vancomycin for Treating Methicillin-Resistant Staphylococcus Aureus Pneumonia in Critically Ill Patients

  2011cited by this paper
• Relationship between Vancomycin Trough Concentrations and Nephrotoxicity: a Prospective Multicenter Trial

  2011cited by this paper
• Vancomycin-associated nephrotoxicity: a critical appraisal of risk with high-dose therapy.

  2011cited by this paper
• Relationship between the MIC of vancomycin and clinical outcome in patients with MRSA nosocomial pneumonia

  2011cited by this paper
• Clinical practice guidelines by the infectious diseases society of america for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children: executive summary.

  2011cited by this paper
• Implementation of a dose calculator for vancomycin to achieve target trough levels of 15-20 microg/mL in persons undergoing hemodialysis.

  2011cited by this paper
• Preferential Emergence of Reduced Vancomycin Susceptibility in Health Care-Associated Methicillin-Resistant Staphylococcus aureus Isolates during Continuous-Infusion Vancomycin Therapy in an In Vitro Dynamic Model

  2011cited by this paper
• Linezolid in the treatment of methicillin-resistant staphylococcal post-neurosurgical meningitis: A series of 17 cases

  2011cited by this paper
• Comparative efficacy of vancomycin and teicoplanin in the treatment of hospitalised elderly patients with persistent meticillin-resistant Staphylococcus aureus (MRSA) bacteraemia.

  2011cited by this paper
• Linezolid for endocarditis: a case series of 14 patients.

  2011cited by this paper
• Relevance of vancomycin-intermediate susceptibility and heteroresistance in methicillin-resistant Staphylococcus aureus bacteraemia.

  2011cited by this paper
• Impact of rpoB Mutations on Reduced Vancomycin Susceptibility in Staphylococcus aureus

  2011cited by this paper
• Vancomycin Way of Administration: Where is the Evidence?

  2011cited by this paper
• Clinical and Laboratory Characteristics of Invasive Infections Due to Methicillin-Resistant Staphylococcus aureus Isolates Demonstrating a Vancomycin MIC of 2 Micrograms per Milliliter: Lack of Effect of Heteroresistant Vancomycin-Intermediate S. aureus Phenotype

  2011cited by this paper
• Vancomycin AUC24/MIC Ratio in Patients with Complicated Bacteremia and Infective Endocarditis Due to Methicillin-Resistant Staphylococcus aureus and Its Association with Attributable Mortality during Hospitalization

  2011cited by this paper
• Epidemiological and molecular aspects of rifampicin-resistant Staphylococcus aureus isolated from wounds, blood and respiratory samples.

  2011cited by this paper
• Determination of Vancomycin and Daptomycin MICs by Different Testing Methods for Methicillin-Resistant Staphylococcus aureus

  2011cited by this paper
• walK and clpP Mutations Confer Reduced Vancomycin Susceptibility in Staphylococcus aureus

  2011cited by this paper
• Impact of vancomycin exposure on outcomes in patients with methicillin-resistant Staphylococcus aureus bacteremia: support for consensus guidelines suggested targets.

  2011cited by this paper
• A higher dose of vancomycin in continuous infusion is needed in critically ill patients.

  2011cited by this paper
• Vancomycin Dosing in Critically Ill Patients: Robust Methods for Improved Continuous-Infusion Regimens

  2011cited by this paper
• Detection of Staphylococcus aureus Isolates with Heterogeneous Intermediate-Level Resistance to Vancomycin in the United States

  2011cited by this paper
• Relationship of vancomycin minimum inhibitory concentration to mortality in patients with methicillin-resistant Staphylococcus aureus hospital-acquired, ventilator-associated, or health-care-associated pneumonia.

  2010cited by this paper
• A rifampicin-containing antibiotic treatment improves outcome of staphylococcal deep sternal wound infections.

  2010cited by this paper
• Dichotomous selection of high-level oxacillin resistance in Staphylococcus aureus by fluoroquinolones.

  2010cited by this paper
• Failure of Vancomycin Continuous Infusion against Experimental Endocarditis Due to Vancomycin-Intermediate Staphylococcus aureus

  2010cited by this paper
• Reduced Vancomycin Susceptibility in Staphylococcus aureus, Including Vancomycin-Intermediate and Heterogeneous Vancomycin-Intermediate Strains: Resistance Mechanisms, Laboratory Detection, and Clinical Implications

  2010cited by this paper
• Unpredictable Effects of Rifampin as an Adjunctive Agent in Elimination of Rifampin-Susceptible and -Resistant Staphylococcus aureus Strains Grown in Biofilms

  2010cited by this paper
• Predictors of persistent methicillin-resistant Staphylococcus aureus bacteraemia in patients treated with vancomycin.

  2010cited by this paper
• Expanded clinical presentation of community-acquired methicillin-resistant Staphylococcus aureus pneumonia.

  2010cited by this paper
• Clinical outcomes and nephrotoxicity associated with vancomycin trough concentrations during treatment of deep-seated infections

  2010cited by this paper
• Increased Mortality with Accessory Gene Regulator (agr) Dysfunction in Staphylococcus aureus among Bacteremic Patients

  2010cited by this paper
• Resistance to rifampicin: at the crossroads between ecological, genomic and medical concerns.

  2010cited by this paper
• Efficacy and safety of rifampin containing regimen for staphylococcal prosthetic joint infections treated with debridement and retention

  2010cited by this paper
• The importance of a judicious and early empiric choice of antimicrobial for methicillin-resistant Staphylococcus aureus bacteraemia

  2010cited by this paper
• Successful Treatment for Carriage of Methicillin-Resistant Staphylococcusaureus and Importance of Follow-Up

  2010cited by this paper
• Comparing antimicrobial susceptibility of meticillin-resistant Staphylococcus aureus (MRSA) to vancomycin using MicroScan (Pos Combo 3.1J) and conventional methods.

  2010cited by this paper
• Comparison of Detection Methods for Heteroresistant Vancomycin-Intermediate Staphylococcus aureus, with the Population Analysis Profile Method as the Reference Method

  2010cited by this paper
• Fatal bacteraemia and infective endocarditis due to meticillin-resistant Staphylococcus aureus (MRSA) with rapid emergence of rifampicin resistance during vancomycin/rifampicin combination treatment.

  2010cited by this paper
• Exposure-response analysis of tigecycline in pharmacodynamic simulations using different size inocula of target bacteria.

  2010cited by this paper
• Systematic Review and Meta-Analysis of the Significance of Heterogeneous Vancomycin-Intermediate Staphylococcus aureus Isolates

  2010cited by this paper
• Heteroresistance to glycopeptides in Italian meticillin-resistant Staphylococcus aureus (MRSA) isolates.

  2010cited by this paper
• Is high vancomycin minimum inhibitory concentration a good marker to predict the outcome of methicillin-resistant Staphylococcus aureus bacteremia?

  2010cited by this paper
• Increasing vancomycin serum trough concentrations and incidence of nephrotoxicity.

  2010cited by this paper
• Systematic Review and Meta-Analysis of the Effectiveness and Safety of Tigecycline for Treatment of Infectious Disease

  2010cited by this paper
• The quest to identify heterogeneously resistant vancomycin-intermediate Staphylococcus aureus strains.

  2010cited by this paper
• Aerosolized vancomycin for the treatment of MRSA after lung transplantation

  2010cited by this paper
• Linezolid treatment of shunt-related cerebrospinal fluid infections in children.

  2010cited by this paper
• Pharmacodynamic effect of clinical vancomycin exposures on cell wall thickness in heterogeneous vancomycin-intermediate Staphylococcus aureus.

  2010cited by this paper
• Risk factors for mortality in patients with persistent methicillin-resistant Staphylococcus aureus bacteraemia in a tertiary care hospital in Taiwan.

  2010cited by this paper
• Effect of vancomycin plus rifampicin in the treatment of nosocomial methicillin-resistant Staphylococcus aureus pneumonia*

  2010cited by this paper
• Comparative Effectiveness of Linezolid and Vancomycin among a National Cohort of Patients Infected with Methicillin-Resistant Staphylococcus aureus

  2010cited by this paper
• Activity of tigecycline against methicillin-resistant Staphylococcus aureus (MRSA) from respiratory tract sources.

  2010cited by this paper
• Staphylococcus aureus Meningitis: Case Series and Literature Review

  2010cited by this paper
• Clinical features of heteroresistant vancomycin-intermediate Staphylococcus aureus bacteremia versus those of methicillin-resistant S. aureus bacteremia.

  2009cited by this paper
• Development and evaluation of vancomycin dosage guidelines designed to achieve new target concentrations.

  2009cited by this paper
• Nine-Hospital Study Comparing Broth Microdilution and Etest Method Results for Vancomycin and Daptomycin against Methicillin-Resistant Staphylococcus aureus

  2009cited by this paper
• Clinical features and treatment outcomes of vancomycin-intermediate Staphylococcus aureus (VISA) and heteroresistant vancomycin-intermediate Staphylococcus aureus (hVISA) in a tertiary care institution in Singapore

  2009cited by this paper
• Persistent Staphylococcus aureus bacteremia: Incidence and outcome trends over time

  2009cited by this paper
• Eradication of methicillin-resistant Staphylococcus aureus carriage: a systematic review.

  2009cited by this paper
• Development of teicoplanin dosage guidelines for patients treated within an outpatient parenteral antibiotic therapy (OPAT) programme.

  2009cited by this paper
• Continuous infusion of vancomycin less effective and safe than intermittent infusion, based on pharmacodynamic and pharmacokinetic principles.

  2009cited by this paper
• Salvage treatment for persistent methicillin-resistant Staphylococcus aureus bacteremia: efficacy of linezolid with or without carbapenem.

  2009cited by this paper
• Relationship between initial vancomycin concentration-time profile and nephrotoxicity among hospitalized patients.

  2009cited by this paper
• Vancomycin MIC plus Heteroresistance and Outcome of Methicillin-Resistant Staphylococcus aureus Bacteremia: Trends over 11 Years

  2009cited by this paper
• Nephrotoxicity of continuous versus intermittent infusion of vancomycin in outpatient parenteral antimicrobial therapy.

  2009cited by this paper
• Vancomycin dosing for pneumonia in critically ill trauma patients.

  2009cited by this paper
• Minocycline--an old drug for a new century: emphasis on methicillin-resistant Staphylococcus aureus (MRSA) and Acinetobacter baumannii.

  2009cited by this paper
• Tigecycline in combination with other antimicrobials: a review of in vitro, animal and case report studies.

  2009cited by this paper
• Therapeutic monitoring of vancomycin in adult patients: a consensus review of the American Society of Health-System Pharmacists, the Infectious Diseases Society of America, and the Society of Infectious Diseases Pharmacists.

  2009cited by this paper
• Staphylococcus aureus bacteraemia: a major cause of mortality in Australia and New Zealand

  2009cited by this paper
• Vancomycin MICs for Staphylococcus aureus Vary by Detection Method and Have Subtly Increased in a Pediatric Population Since 2005

  2009cited by this paper

• Efficacy and safety of antistaphylococcal penicilin or cephazolin-based combinations versus monotherapy for methicillin-susceptible Staphylococcus aureus infective endocarditis. A propensity score analysis of nationwide prospective cohort.

  2024cites this paper
• Prevalencia y factores de riesgo de infección por Staphylococcus aureus resistente a meticilina en niños

  2024cites this paper
• DETECCIÓN DE METABOLITOS SECUNDARIOS PRESENTES EN LAS HOJAS DE (Trichanthera gigantea) ACANTHACEAE Y SU ACTIVIDAD ANTIMICROBIANA Y ANTIMICÓTICA

  2023cites this paper
• The Use of Clinical Prediction Rules without Echocardiographic Evaluation in Staphylococcus aureus bacteraemia may not be Enough to Exclude Infective Endocarditis and be Associated with Increased Mortality

  2022cites this paper
• In vitro synergistic interaction between Melaleuca armillaris essential oil and erythromycin against Staphylococcus aureus isolated from dairy cows

  2022cites this paper
• Unreliability of Clinical Prediction Rules to Exclude without Echocardiography Infective Endocarditis in Staphylococcus aureus Bacteremia

  2022cites this paper
• Comparison of in vitro anti-Staphylococcus aureus activity of eight antibiotics and four dilutions of propolis

  2022cites this paper
• Modelling the Growth and Death of Staphylococcus aureus against Melaleuca armillaris Essential Oil at Different pH Conditions

  2021cites this paper
• Modeling the Growth and Death of Staphylococcus aureus against Melaleuca armillaris Essential Oil at Different pH Conditions

  2021cites this paper
• Study of methodologies for the formation of a layer that inhibits the formation of bacterial strains in cardiac instruments

  2021cites this paper
• Vancomycin-associated acute kidney injury in Hong Kong in 2012–2016

  2020cites this paper
• Estudio comparativo del efecto antibacteriano de tres marcas del tocosh (Solanum tuberosum) frente a staphylococcus aureus ATCC 25923 Arequipa-2019

  2020cites this paper
• Evaluación de la actividad in vitro de combinaciones antibacterianas frente a Staphylococcus aureus meticilino resistente

  2020cites this paper
• Staphylococcus aureus y susceptibilidad de un hospital Nivel II en Palmira-Colombia

  2020cites this paper
• Evaluación del halo de inhibición de la planta Otholobium mexicanum frente a Staphylococcuss aureaus ATCC 25923

  2019cites this paper
• Características clínicas y epidemiológicas en pacientes con piodermitis atendidos en un hospital general

  2019cites this paper
• Staphylococcus aureus colonization in an institutionalized elderly population in the Bay of Cadiz area, Spain: Prevalence and associated risk factors

  2019cites this paper
• Colonización por Staphylococcus aureus en población anciana institucionalizada en el área de la Bahía de Cádiz: prevalencia y factores de riesgo asociados

  2019cites this paper
• Efecto sinérgico del aceite esencial de cymbopogon citratus sobre la actividad de oxacilina, clindamicina y cotrimoxazol contra staphylococcus aureus

  2018cites this paper
• Combination of Cloxacillin and Essential Oil of Melaleuca armillaris as an Alternative Against Staphylococcus aureus

  2018cites this paper
• Efecto Antimicrobiano del Aceite Esencial de Eucalyptus Globulus “Eucalipto”, sobre Staphylococcus Aureus ATCC25923 comparado con Oxacilina

  2018cites this paper
• Caracterización de neumonía por Staphylococcus aureus meticilino resistente en hospital militar de alta complejidad

  2018cites this paper
• Evaluación del potencial antimicrobiano de extractos de plantas frente a microorganismos asociados a conjuntivitis bacterianas

  2018cites this paper
• Staphylococcus aureus con resistencia inducible a clindamicina causante de infección de tejidos blandos, en el Hospital para el Niño Poblano

  2018cites this paper
• Efecto antimicrobiano de la combinación de cloxacilina con aceite esencial de Melaleuca armillaris frente a Staphylococcus aureus

  2017cites this paper
• Las infecciones de la piel y partes blandas en el recién nacido

  2017cites this paper
• Current and future trends in antibiotic therapy of acute bacterial skin and skin-structure infections.

  2016cites this paper
• Current guidelines and recommendations for the management of skin and soft tissue infections

  2016cites this paper
• Staphylococcus aureus con resistencia múltiple a los antibióticos (MDR) en un Hospital de Maracaibo- Venezuela Multidrug-resistant (MDR) Staphylococcus aureus in a Maracaibo's hospital, Venezuela

  2016cites this paper
• FACULTAD DE FARMACIA UNIVERSIDAD COMPLUTENSE

  2015cites this paper
• Furunculosis recurrente familiar producida por un clon comunitario de Staphylococcus aureus resistente a meticilina (SARM) multirresistente productor de leucocidina de Panton Valentine (LPV)

  2015cites this paper
• Determinación del efecto antimicrobiano in vitro de un gel elaborado con extracto etanólico de hojas de Senecio rhizomatus Rusby (Asteraceae)

  2015cites this paper
• Protocolo de tratamiento empírico de la osteomielitis

  2014cites this paper
• Infecciones por estafilococos

  2014cites this paper
• Guía de consenso para el abordaje de la neumonía adquirida en la comunidad en el paciente anciano

  2014cites this paper
• European perspective and update on the management of complicated skin and soft tissue infections due to methicillin-resistant Staphylococcus aureus after more than 10 years of experience with linezolid.

  2014cites this paper
• [Trend in the susceptibility of the most frequent bacterial pathogens isolated at Hospital General La Mancha Centro over 2010-2012 period].

  2014cites this paper
• Guidelines for the management of community-acquired pneumonia in the elderly patient.

  2014cites this paper
• Dosis superior a 6 mg/kg/día de daptomicina según parámetros farmacocinéticos/farmacodinámicos en infecciones por Staphylococcus aureus

  2013cites this paper
• Formación médica continuada: Infección nosocomial. Fundamentos y actuación clínica Infecciones causadas por bacterias grampositivas multirresistentes (Staphylococcus aureus y Enterococcus spp.)

  2013cites this paper
• [Infections caused by multi-resistant Gram-positive bacteria (Staphylococcus aureus and Enterococcus spp.)].

  2013cites this paper